Preoperative CA 125 is significant indicator of curative resection in gastric cancer patients

World Journal of Gastroenterology

Volumn 21, Issue 4, 2015, Pages 1216-1221

  Kim, Dae Hoon ^a   Yun, Hyo Yung ^a   Ryu, Dong Hee ^a   Han, Hye Suk ^a   Han, Joung Ho ^a   Yoon, Soon Man ^a   Youn, Sei Jin ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

Carbohydrate antigen 125; Carbohydrate antigen 19 9; Carcinoembryonic antigen; Gastric Cancer; Tumor Marker

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ELECTIVE GASTRECTOMY; ELECTIVE SURGERY; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERITONEUM METASTASIS; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RETROSPECTIVE STUDY; STOMACH CANCER; AGED; BLOOD; CHI SQUARE DISTRIBUTION; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84921727257     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i4.1216     Document Type: Article

References (28)

1. Grem J. The prognostic importance of tumor markers in adenocarcinomas of the gastrointestinal tract. Curr Opin Oncol 1997; 9: 380-387 [PMID: 9251889 doi: 10.1097/00001622-19970 9040-00012]
2. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986; 104: 66-73 [PMID: 3510056 doi: 10.7326/0003-4819-104-1-66]
3. Lamerz R. Role of tumour markers, cytogenetics. Ann Oncol 1999; 10 Suppl 4: 145-149 [PMID: 10436809 doi: 0.1093/annonc/10.suppl-4.s145]
4. Reiter W, Stieber P, Reuter C, Nagel D, Cramer C, Pahl H, Fateh-Moghadam A. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Anticancer Res 1997; 17: 2903-2906 [PMID: 9329559]
5. Marrelli D, Roviello F, De Stefano A, Farnetani M, Garosi L, Messano A, Pinto E. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999; 57: 55-62 [PMID: 10394126 doi: 10.1159/000012001]
6. American Joint of Commutee on Cancer. AJCC cancer staging manual 7th edition. New York: Springer, 2010: 117-121 [doi: 10.1007/978-0-387-88441-7]
7. Cragun JM. Screening for ovarian cancer. Cancer Control 2011; 18: 16-21 [PMID: 21273976]
8. Ucar E, Semerci E, Ustun H, Yetim T, Huzmeli C, Gullu M. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther 2008; 25: 1075-1084 [PMID: 18821070 doi: 10.1007/s12325-008-0100-4]
9. Nakata B, Hirakawa-YS Chung K, Kato Y, Yamashita Y, Maeda K, Onoda N, Sawada T, Sowa M. Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma. Cancer 1998; 83: 2488-2492 [PMID: 9874453]
10. Kim DH, Kim SM, Hyun JK, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods. Ann Surg Oncol 2013; 20: 2317-2327 [PMID: 23677605 doi: 10.1245/s10434-012-2700-0]
11. Leake PA, Cardoso R, Seevaratnam R, Lourenco L, Helyer L, Mahar A, Law C, Coburn NG. A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer. Gastric Cancer 2012; 15 Suppl 1: S38-S47 [PMID: 21667136 doi: 10.1007/s10120-011-0047-z]
12. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-123 [PMID: 21573742 doi: 10.1007/s10120-011-0042-4]
13. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002: 89-99
14. Hur H, Song KY, Park CH, Jeon HM. Follow-up strategy after curative resection of gastric cancer: a nationwide survey in Korea. Ann Surg Oncol 2010; 17: 54-64 [PMID: 19777193 doi: 10.1245/s10434-009-0676-1]
15. Heptner G, Domschke S, Domschke W. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies. Scand J Gastroenterol 1989; 24: 745-750 [PMID: 2814339 doi: 10.3109/00365528909093116]
16. Pectasides D, Mylonakis A, Kostopoulou M, Papadopoulou M, Triantafillis D, Varthalitis J, Dimitriades M, Athanassiou A. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma. Am J Clin Oncol 1997; 20: 348-353 [PMID: 9256887 doi: 10.1097/0000042 1-199708000-00005]
17. Filella X, Fuster J, Molina R, Grau JJ, García-Valdecasas JC, Grande L, Estapé J, Ballesta AM. TAG-72, CA 19.9 and CEA as tumor markers in gastric cancer. Acta Oncol 1994; 33: 747-751 [PMID: 7993641 doi: 10.3109/02841869409083943]
18. Kim DH, Oh SJ, Oh CA, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy. J Surg Oncol 2011; 104: 585-591 [PMID: 21695697 doi: 10.1002/jso.21919]
19. Gaspar MJ, Arribas I, Coca MC, Díez-Alonso M. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma. Tumour Biol 2001; 22: 318-322 [PMID: 11553862 doi: 10.1159/000050633]
20. He CZ, Zhang KH, Li Q, Liu XH, Hong Y, Lv NH. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. BMC Gastroenterol 2013; 13: 87 [PMID: 23672279 doi: 10.1186/1471-230x-13-87]
21. Lai IR, Lee WJ, Huang MT, Lin HH. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 2002; 49: 1157-1160 [PMID: 12143226]
22. Hwang GI, Yoo CH, Sohn BH, Shin JH, Park YL, Kim HD, Kim YS, Han WK, Pae WK. Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma. Cancer Res Treat 2004; 36: 178-181 [PMID: 20396541 doi: 10.4143/crt.2004.36.3.178]
23. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359: 453-462 [PMID: 18669424 doi: 10.1056/NEJMoa0707035]
24. Huang KH, Wu CW, Fang WL, Chen JH, Lo SS, Wang RF, Li AF. Palliative resection in noncurative gastric cancer patients. World J Surg 2010; 34: 1015-1021 [PMID: 20145923 doi: 10.1007/s00268-010-0467-7]
25. Wang CS, Chao TC, Jan YY, Jeng LB, Hwang TL, Chen MF. Benefits of palliative surgery for far-advanced gastric cancer. Chang Gung Med J 2002; 25: 792-802 [PMID: 12635835]
26. Kwee RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol 2007; 25: 2107-2116 [PMID: 17513817 doi: 10.1200/jco.2006.09.5224]
27. D'Elia F, Zingarelli A, Palli D, Grani M. Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur Radiol 2000; 10: 1877-1885 [PMID: 11305564 doi: 10.1007/s003300000537]
28. Kapiev A, Rabin I, Lavy R, Chikman B, Shapira Z, Kais H, Poluksht N, Amsalam Y, Halpern Z, Markon I, Wassermann I, Halevy A. The role of diagnostic laparoscopy in the management of patients with gastric cancer. Isr Med Assoc J 2010; 12: 726-728 [PMID: 21348398]